Mark E. Bertels - 05 Dec 2024 Form 4 Insider Report for CORVEL CORP (CRVL)

Reporting relationship: EVP - Risk Management Services
Issuer ticker: CRVL
Reported as of: 05 Dec 2024
Net transaction value: -$106,630
SEC form: 4
Accepted by SEC: 09 Dec 2024, 13:41:53 UTC
Prior SEC filing: 02 Oct 2024
Next SEC filing: 16 Jan 2025
Source filing: View source filing
Reporting owner signature: By: Sharon O'Connor For: Mark Bertels

Key filing fact

Mark E. Bertels filed Form 4 for CORVEL CORP (CRVL) on 09 Dec 2024.

Key facts

This page summarizes Mark E. Bertels's Form 4 filing for CORVEL CORP (CRVL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Dec 2024, 13:41.

Change

Previous filing in this sequence was filed on 02 Oct 2024.
Current net transaction value: -$106,630.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVL transaction

Common Stock

Options Exercise

Transaction value: $18,442
Shares: +350
Change %: +41%
Price: $52.69
Shares after: 1,210
Date: 05 Dec 2024
Ownership: Direct

CRVL transaction

Common Stock

Sale

Transaction value: $125,071
Shares: -350
Change %: -29%
Price: $357.35
Shares after: 860
Date: 05 Dec 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVL transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -350
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Dec 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 350
Exercise price: $52.69
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .